312 related articles for article (PubMed ID: 23835716)
1. MicroRNA signature obtained from the comparison of aggressive with indolent non-Hodgkin lymphomas: potential prognostic value in mantle-cell lymphoma.
Goswami RS; Atenafu EG; Xuan Y; Waldron L; Reis PP; Sun T; Datti A; Xu W; Kuruvilla J; Good DJ; Lai R; Church AJ; Lam WS; Baetz T; Lebrun DP; Sehn LH; Farinha P; Jurisica I; Bailey DJ; Gascoyne RD; Crump M; Kamel-Reid S
J Clin Oncol; 2013 Aug; 31(23):2903-11. PubMed ID: 23835716
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA expression, chromosomal alterations, and immunoglobulin variable heavy chain hypermutations in Mantle cell lymphomas.
Navarro A; Beà S; Fernández V; Prieto M; Salaverria I; Jares P; Hartmann E; Mozos A; López-Guillermo A; Villamor N; Colomer D; Puig X; Ott G; Solé F; Serrano S; Rosenwald A; Campo E; Hernández L
Cancer Res; 2009 Sep; 69(17):7071-8. PubMed ID: 19690137
[TBL] [Abstract][Full Text] [Related]
3. [Expression of SOX11 mRNA in mantle cell lymphoma and its clinical significance].
Wang YY; Yu Z; Yi SH; Li ZJ; Li CH; Xie ZQ; Li F; Zang MR; Hao M; Qiu LG
Zhonghua Xue Ye Xue Za Zhi; 2012 Jul; 33(7):556-60. PubMed ID: 22967417
[TBL] [Abstract][Full Text] [Related]
4. Five-gene model to predict survival in mantle-cell lymphoma using frozen or formalin-fixed, paraffin-embedded tissue.
Hartmann E; Fernàndez V; Moreno V; Valls J; Hernández L; Bosch F; Abrisqueta P; Klapper W; Dreyling M; Hoster E; Müller-Hermelink HK; Ott G; Rosenwald A; Campo E
J Clin Oncol; 2008 Oct; 26(30):4966-72. PubMed ID: 18606985
[TBL] [Abstract][Full Text] [Related]
5. p27(Kip1) immunostaining for the differential diagnosis of small b-cell neoplasms in trephine bone marrow biopsies.
Kremer M; Dirnhofer S; Nickl A; Hoefler H; Quintanilla-Martínez L; Fend F
Mod Pathol; 2001 Oct; 14(10):1022-9. PubMed ID: 11598173
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results From Randomized Trials of the European Mantle Cell Lymphoma Network.
Hoster E; Rosenwald A; Berger F; Bernd HW; Hartmann S; Loddenkemper C; Barth TF; Brousse N; Pileri S; Rymkiewicz G; Kodet R; Stilgenbauer S; Forstpointner R; Thieblemont C; Hallek M; Coiffier B; Vehling-Kaiser U; Bouabdallah R; Kanz L; Pfreundschuh M; Schmidt C; Ribrag V; Hiddemann W; Unterhalt M; Kluin-Nelemans JC; Hermine O; Dreyling MH; Klapper W
J Clin Oncol; 2016 Apr; 34(12):1386-94. PubMed ID: 26926679
[TBL] [Abstract][Full Text] [Related]
7. Multicenter phase II study of bendamustine for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma.
Ohmachi K; Ando K; Ogura M; Uchida T; Itoh K; Kubota N; Ishizawa K; Yamamoto J; Watanabe T; Uike N; Choi I; Terui Y; Usuki K; Nagai H; Uoshima N; Tobinai K;
Cancer Sci; 2010 Sep; 101(9):2059-64. PubMed ID: 20626754
[TBL] [Abstract][Full Text] [Related]
8. microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma.
Zhao JJ; Lin J; Lwin T; Yang H; Guo J; Kong W; Dessureault S; Moscinski LC; Rezania D; Dalton WS; Sotomayor E; Tao J; Cheng JQ
Blood; 2010 Apr; 115(13):2630-9. PubMed ID: 20086245
[TBL] [Abstract][Full Text] [Related]
9. Methylation of miR-155-3p in mantle cell lymphoma and other non-Hodgkin's lymphomas.
Yim RL; Wong KY; Kwong YL; Loong F; Leung CY; Chu R; Lam WW; Hui PK; Lai R; Chim CS
Oncotarget; 2014 Oct; 5(20):9770-82. PubMed ID: 25211095
[TBL] [Abstract][Full Text] [Related]
10. Mantle cell lymphoma: 2012 update on diagnosis, risk-stratification, and clinical management.
Vose JM
Am J Hematol; 2012 Jun; 87(6):604-9. PubMed ID: 22615102
[TBL] [Abstract][Full Text] [Related]
11. Detection of cyclin D1 overexpression by real-time reverse-transcriptase-mediated quantitative polymerase chain reaction for the diagnosis of mantle cell lymphoma.
Suzuki R; Takemura K; Tsutsumi M; Nakamura S; Hamajima N; Seto M
Am J Pathol; 2001 Aug; 159(2):425-9. PubMed ID: 11485900
[TBL] [Abstract][Full Text] [Related]
12. Should there be a standard therapy for mantle cell lymphoma?
Smith MR
Future Oncol; 2011 Feb; 7(2):227-37. PubMed ID: 21345142
[TBL] [Abstract][Full Text] [Related]
13. TCL1 expression predicts overall survival in patients with mantle cell lymphoma.
Shin SJ; Roh J; Cha HJ; Choi YD; Kim JM; Min SK; Kim JE; Eom DW; Lee H; Kim HJ; Yoon DH; Suh C; Huh J
Eur J Haematol; 2015 Dec; 95(6):583-94. PubMed ID: 25688912
[TBL] [Abstract][Full Text] [Related]
14. A B-cell receptor-related gene signature predicts survival in mantle cell lymphoma: results from the Fondazione Italiana Linfomi MCL-0208 trial.
Bomben R; Ferrero S; D'Agaro T; Dal Bo M; Re A; Evangelista A; Carella AM; Zamò A; Vitolo U; Omedè P; Rusconi C; Arcaini L; Rigacci L; Luminari S; Piccin A; Liu D; Wiestner A; Gaidano G; Cortelazzo S; Ladetto M; Gattei V
Haematologica; 2018 May; 103(5):849-856. PubMed ID: 29472356
[TBL] [Abstract][Full Text] [Related]
15. MiR-132-3p serves as a tumor suppressor in mantle cell lymphoma via directly targeting SOX11.
Wu B; Li J; Wang H; Wu Q; Liu H
Naunyn Schmiedebergs Arch Pharmacol; 2020 Nov; 393(11):2197-2208. PubMed ID: 32040593
[TBL] [Abstract][Full Text] [Related]
16. Identification of miR-15b as a transformation-related factor in mantle cell lymphoma.
Arakawa F; Kimura Y; Yoshida N; Miyoshi H; Doi A; Yasuda K; Nakajima K; Kiyasu J; Niino D; Sugita Y; Tashiro K; Kuhara S; Seto M; Ohshima K
Int J Oncol; 2016 Feb; 48(2):485-92. PubMed ID: 26676972
[TBL] [Abstract][Full Text] [Related]
17. Hospice Use Among Patients With Lymphoma: Impact of Disease Aggressiveness and Curability.
Odejide OO; Cronin AM; Earle CC; LaCasce AS; Abel GA
J Natl Cancer Inst; 2016 Jan; 108(1):. PubMed ID: 26438575
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic profile and first preliminary clinical evaluation of bendamustine in Taiwanese patients with heavily pretreated indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma.
Hsiao LT; Tien HF; Kuo CY; Wu JH; Hou HA; Wang MC; Liu CY; Chen PM; Chiou TJ
Hematol Oncol; 2015 Dec; 33(4):136-44. PubMed ID: 25111959
[TBL] [Abstract][Full Text] [Related]
19. Phase I and pharmacokinetic study of bendamustine hydrochloride in relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma.
Ogura M; Uchida T; Taniwaki M; Ando K; Watanabe T; Kasai M; Matsumoto Y; Shimizu D; Ogawa Y; Ohmachi K; Yokoyama H; Tobinai K;
Cancer Sci; 2010 Sep; 101(9):2054-8. PubMed ID: 20594195
[TBL] [Abstract][Full Text] [Related]
20. Cyclin D1-negative blastoid mantle cell lymphoma identified by SOX11 expression.
Zeng W; Fu K; Quintanilla-Fend L; Lim M; Ondrejka S; Hsi ED
Am J Surg Pathol; 2012 Feb; 36(2):214-9. PubMed ID: 22251940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
